Community

Our community narratives are driven by numbers and valuation.

Value any stock for free in seconds

Get alerts and valuation updates

Participate in discussions

Weekly Picks

RNXT logo
RenovoRx
ST
Stock_Research_Today
Community Contributor

Revolutionizing Cancer Treatment

A Precision Approach to Hard-to-Treat Cancers RenovoRx, Inc. (Nasdaq: RNXT), based in Mountain View, California, is a clinical-stage biopharma company taking a new approach to cancer treatment.
View narrative
US$4.20
FV
71.9% undervalued intrinsic discount
371.30%
Revenue growth p.a.
10users have liked this narrative
0users have commented on this narrative
77users have followed this narrative
19 days ago author updated this narrative
AAPL logo
Apple
IN
Investingwilly
Community Contributor

Apple: A Dying Star with an Overpriced Valuation

Intro Apple Inc. (AAPL) has long been one of the most beloved stocks in the market, celebrated for its sleek products and loyal customer base.
View narrative
US$177.34
FV
19.1% overvalued intrinsic discount
14.68%
Revenue growth p.a.
13users have liked this narrative
0users have commented on this narrative
54users have followed this narrative
4 days ago author updated this narrative
ASM logo
Avino Silver & Gold Mines
AG
Agricola
Community Contributor

Avino a case for USD$20 per share within 5 years (assuming $3,500 gold, $100 silver and $4 copper).

Full disclosure. I am a shareholder at the time of writing this.
View narrative
CA$26.79
FV
86.0% undervalued intrinsic discount
78.01%
Revenue growth p.a.
15users have liked this narrative
0users have commented on this narrative
41users have followed this narrative
19 days ago author updated this narrative

Community Investing Ideas

Load previous narratives
RACE logo
Ferrari
AN
AnalystConsensusTarget
Consensus Narrative from 13 Analysts

New Electric Models And Flexible Production Will Boost Market Presence

Key Takeaways Expanded production and personalization options are expected to boost revenue and increase flexibility. Launch of new electric models and sustainability initiatives may enhance brand reputation and revenue growth.
View narrative
€435.48
FV
2.5% overvalued intrinsic discount
8.39%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
15 days ago author updated this narrative
OUT1V logo
Outokumpu Oyj
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts

Germany Production Centralization And Ferrochrome Focus Will Unlock Future Potential

Key Takeaways Centralizing production and cost-saving measures aim to improve profitability and enhance net margins by the targeted year. Growing demand for low-emission ferrochrome and possible U.S. tariff protections may boost revenue and market positioning.
View narrative
€3.58
FV
5.6% undervalued intrinsic discount
6.25%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
15 days ago author updated this narrative
YOU logo
YouGov
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts

SP3 Focus And Scandinavian Expansion Will Drive Success

Key Takeaways Commitment to SP3 strategy and AI enhancements suggest potential revenue growth and improved product offerings through technology and automation. Cost optimization and expansion into new regions indicate improved financial performance and market diversification potential.
View narrative
UK£5.61
FV
43.5% undervalued intrinsic discount
3.82%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
15 days ago author updated this narrative
UNI logo
Universal Store Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts

Perfect Stranger And Neovision Will Broaden Retail Opportunities

Key Takeaways Expansion of store network, with Perfect Stranger brand focus, aims to drive revenue growth through higher conversion rates than online sales. Increased private brand penetration and premium pricing strategies are expected to boost gross margins and earnings.
View narrative
AU$9.91
FV
15.8% undervalued intrinsic discount
9.96%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
15 days ago author updated this narrative
XRAY logo
DENTSPLY SIRONA
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts

Revamped E-commerce And Imaging Products Will Secure Success

Key Takeaways Strategic divestment of Wellspect HealthCare aims to unlock value and improve net margins, leveraging its growth and profitability. Focus on innovation and e-commerce in aligners and new product launches expects revenue growth and margin improvements in key segments.
View narrative
US$18.14
FV
8.0% undervalued intrinsic discount
-0.15%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
15 days ago author updated this narrative
MDGL logo
Madrigal Pharmaceuticals
AN
AnalystConsensusTarget
Consensus Narrative from 15 Analysts

FDA Approval Will Expand MASH Treatment Market Reach

Key Takeaways First FDA-approved MASH treatment and strong U.S. market launch position Madrigal Pharmaceuticals for significant revenue growth. Strategic team enhancements and international market expansion efforts could bolster efficiencies and enhance future net margins.
View narrative
US$417.60
FV
30.3% undervalued intrinsic discount
82.53%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
15 days ago author updated this narrative
CAPR logo
Capricor Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts

FDA Priority Review And NS Pharma Partnership Will Empower Deramiocel

Key Takeaways FDA priority review of deramiocel and partnership with NS Pharma could drive significant revenue growth and market penetration. Expanded manufacturing capabilities and milestone payments enhance financial position, supporting demand and potential future growth.
View narrative
US$43.71
FV
78.4% undervalued intrinsic discount
103.05%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
15 days ago author updated this narrative